通过增强的分子模拟揭示了改进的CGRP结动学的决定因素
Ceren Kilinc1, Katie M Babin2, Augen A Pioszak2
1Michigan State University, Department of Biochemistry and Molecular Biology, East Lansing, Michigan 48824, USA.
Biophysical journal
|March 11, 2026
概括
工程化酸具有较长的结合时间,与类受体类受体:受体活性修饰蛋白1 (CLR:RAMP1) 复合体结合. 这种增长的停留时间对于药物疗效至关重要,源于改进的连接物重新捕获和稳定相互作用.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 类提供治疗优势,如效力和安全性.
- 优化-药物动力学,如结合的停留时间,是有效性和稳定性的关键.
- 类似于受体的受体:受体活性修饰蛋白1 (CLR:RAMP1) 复合物及其激素,受体基因相关 (CGRP),都与偏头痛有关.
研究的目的:
- 为了比较分析原生CGRP和工程变体ssCGRP的解绑机制.
- 为了阐明ssCGRP在CLR:RAMP1复合体中增强的停留时间的分子基础.
- 为设计下一代疗法提供洞察力,以优化动力性质.
主要方法:
- 利用一个高维权集算法来取样解绑路径.
- 采用马尔科夫状态建模,用于对过渡状态组合进行比较分析.
- 分析了结合和解结合期间的分子内和分子间稳定相互作用.
主要成果:
- 与原生CGRP相比,sssCGRP在CLR:RAMP1复合体中的停留时间长了430倍.
- ssCGRP证明了中介解结合形状的增强回收.
- ssCGRP采样了一个更加异质的边界状态组合,导致了稳定.
结论:
- 这项研究确定了负责ssCGRP增强居住时间的分子决定因素.
- 这些发现为合理设计长效疗法提供了宝贵的见解.
- 了解蛋白结合动力学对于优化药物的疗效和作用时间至关重要.
更多相关视频
05:57Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
Published on: April 26, 2024
942
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
9.1K
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Protein-Drug Binding: Mechanism and Kinetics
2.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
